These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 37514022

  • 1. Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges.
    Cheli S, Savino D, Penagini F, Zuccotti G, Zuin G, Clementi E, Cattaneo D.
    Pharmaceutics; 2023 Jun 27; 15(7):. PubMed ID: 37514022
    [Abstract] [Full Text] [Related]

  • 2. Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kits.
    Bertin D, Serrero M, Grimaud JC, Desjeux A, Desplat-Jégo S.
    Cytokine; 2020 Feb 27; 126():154859. PubMed ID: 31629989
    [Abstract] [Full Text] [Related]

  • 3. Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits.
    Laserna-Mendieta EJ, Salvador-Martín S, Arias-González L, Ruiz-Ponce M, Menchén LA, Sánchez C, López-Fernández LA, Lucendo AJ.
    Clin Chem Lab Med; 2019 Nov 26; 57(12):1906-1914. PubMed ID: 31085742
    [Abstract] [Full Text] [Related]

  • 4. Analytical and clinical performance evaluation of two POC tests for therapeutic drug monitoring of infliximab.
    Van den Bossche D, De Smet D, Debrabandere J, Vanpoucke H.
    Clin Chem Lab Med; 2019 May 27; 57(6):856-863. PubMed ID: 30838834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits.
    Laserna-Mendieta EJ, Salvador-Martín S, Marín-Jiménez I, Menchén LA, López-Cauce B, López-Fernández LA, Lucendo AJ.
    J Pharm Biomed Anal; 2021 May 10; 198():114003. PubMed ID: 33714800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseases.
    Villemonteix J, Guérin-El Khourouj V, Hugot JP, Giardini C, Carcelain G, Martinez-Vinson C.
    Biologicals; 2021 Apr 10; 70():17-21. PubMed ID: 33676831
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
    Nasser Y, Labetoulle R, Harzallah I, Berger AE, Roblin X, Paul S.
    Dig Dis Sci; 2018 Oct 10; 63(10):2714-2721. PubMed ID: 29948562
    [Abstract] [Full Text] [Related]

  • 15. Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies.
    Sam MJ, Connor SJ, Ng WW, Toong CM.
    Ther Drug Monit; 2020 Dec 10; 42(6):821-828. PubMed ID: 32947553
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    Jourdil JF, Némoz B, Gautier-Veyret E, Romero C, Stanke-Labesque F.
    Ther Drug Monit; 2018 Aug 10; 40(4):417-424. PubMed ID: 29608486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.